The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of immune checkpoint inhibitors (ICI) in biliary tract cancer (BTC): Real-world outcomes and predictive factors.
 
Amir Sara
No Relationships to Disclose
 
Anne Noonan
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I); DAVA Pharmaceuticals; Deciphera (I); Eisai; Elevar Therapeutics; Exelixis; GOG Foundation (I); Helsinn Healthcare; Immunogen (I); Merck (I); OncLive/MJH Life Sciences; OncLive/MJH Life Sciences (I); QED Therapeutics; Taiho Pharmaceutical
 
Arjun Mittra
Stock and Other Ownership Interests - Lilly
Research Funding - Tempus (Inst); THERIVA BIOLOGICS, SL. (Inst)
 
Ning Jin
No Relationships to Disclose
 
Pannaga Malalur
Honoraria - OncLive/MJH Life Sciences
 
Shafia Rahman
No Relationships to Disclose
 
Sameek Roychowdhury
Stock and Other Ownership Interests - Johnson & Johnson (I)
Honoraria - Illumina; Integrated DNA Technologies
Consulting or Advisory Role - AbbVie; Incyte; Incyte; Merck; QED Therapeutics; Seagen
Research Funding - Ignyta; Incyte; QED Therapeutics; Takeda
 
John Hays
Consulting or Advisory Role - AADi; Alkermes; AstraZeneca; Clovis Oncology; Deciphera; Immunogen; Ipsen; Merck; Mersana; Mural Oncology; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Merck; Regeneron; Tesaro
 
Ashish Manne
Honoraria - Onclive
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Cardinal Health